Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1990 Jun;34(6):1268–1270. doi: 10.1128/aac.34.6.1268

Influence of temperature on degradation kinetics of ceftriaxone in diluted and undiluted human serum.

M J Esteban 1, E Cantón 1, F Rius 1
PMCID: PMC171798  PMID: 2393289

Abstract

The stability of ceftriaxone in undiluted human serum and in human serum diluted 1/20 in 0.1 M phosphate buffer (pH 6.0) was measured at -70, -40, -20, 4, and 37 degrees C. Ceftriaxone in diluted human serum contained at least 90% of the initial activity after 3 months of storage at -20, -40, and -70 degrees C; unbuffered human serum contained 82.41, 84.92, and 88.96% of the initial activity, respectively. Ceftriaxone in unbuffered human serum and in diluted human serum showed 80.33 and 86.25% of the initial activity, respectively, after 55 days at 4 degrees C. After 120 h at 37 degrees C, this antibiotic in unbuffered human serum contained 33.08% of the initial activity, whereas samples of diluted human serum contained more than 60%. Consequently, the stability of antibiotic in human serum diluted 1/20 in 0.1 M phosphate buffer (pH 6.0) is increased.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broughall J. M., Bywater M. J., Holt H. A., Reeves D. S. Stabilization of cephalosporins in serum and plasma. J Antimicrob Chemother. 1979 Jul;5(4):471–472. doi: 10.1093/jac/5.4.471. [DOI] [PubMed] [Google Scholar]
  2. Bundgaard H., Hansen J. Reaction of ampicillin with serum albumin to produce penicilloyl-protein conjugates and a piperazinedione. J Pharm Pharmacol. 1982 May;34(5):304–309. doi: 10.1111/j.2042-7158.1982.tb04712.x. [DOI] [PubMed] [Google Scholar]
  3. Fabre H., Eddine N. H., Berge G. Degradation kinetics in aqueous solution of cefotaxime sodium, a third-generation cephalosporin. J Pharm Sci. 1984 May;73(5):611–618. doi: 10.1002/jps.2600730508. [DOI] [PubMed] [Google Scholar]
  4. Miles A. A., Maskell J. P. The neutralization of antibiotic action by metallic cations and iron chelators. J Antimicrob Chemother. 1986 Apr;17(4):481–487. doi: 10.1093/jac/17.4.481. [DOI] [PubMed] [Google Scholar]
  5. Neu H. C., Meropol N. J., Fu K. P. Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin. Antimicrob Agents Chemother. 1981 Mar;19(3):414–423. doi: 10.1128/aac.19.3.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. O'Callaghan C. H. Irreversible effects of serum proteins on beta-lactam antibiotics. Antimicrob Agents Chemother. 1978 Apr;13(4):628–633. doi: 10.1128/aac.13.4.628. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Stoeckel K. Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life. Chemotherapy. 1981;27 (Suppl 1):42–46. doi: 10.1159/000238028. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES